In addition, mutations in TLR1 and TLR6 receptors are associated with differential susceptibility to bacterial and fungal infections [15], [21], and the question arises to what extent these polymorphisms may lead to changes in production of cytokines after exposure to Borrelia species, and hence might influence the clinical outcome of Lyme disease. This evidence concerns the gene TLR1 and Lyme disease.